Azamat Baymukanov

Dr. Azamat Baymukanov

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2021 in Kardiologiia
Verified
Journal Article
Open access
PDF file
IKI. V. Kovtyukh
I. V. Kovtyukh
GGG. E. Gendlin
G. E. Gendlin
INIGOR G. NIKITIN
IGOR G. NIKITIN
ABAzamat Baymukanov
Azamat Baymukanov
ANA. E. Nikitin
A. E. Nikitin
SDS. N. Dvornikova
S. N. Dvornikova
Background Heart damage is one of complications of the novel coronavirus infection. Searching for available predictors for in-hospital death and survival that determine the tactic of managing patients with COVID-19, is a challenge of the present time. Aim To determine the role echocardiographic (EchoCG) parameters in evaluation of the in-hospital prognosis for patients with the novel coronavirus infection, COVID-19. Material and methods The study included 158 patients admitted for COVID-19. EchoCG was performed for all patients. The role of left ventricular (LV) ejection fraction (EF) was analyzed in various age groups. EchoCG data were compared with the clinical picture, including the severity of respiratory failure (RF), blood oxygen saturation (SрО2), data of computed tomography (CT) of the lungs, and blood concentration of troponin. Comorbidity was analyzed, and the highest significance of individual pathologies was determined . Results LV EF ≤40 % determined the worst prognosis of patients with COVID-19 (p<0.0001), including the age group older than 70 years (р=0.013). LV EF did not correlate with the degree of lung tissue damage determined by CT upon admission (р=0.54) and over time (р=0.23). The indexes that determined an adverse in-hospital prognosis to a considerable degree were pericardial effusion (p<0.0001) and pulmonary hypertension (p<0.0001). RV end-diastolic dimension and LV end-diastolic volume did not determine the in-hospital mortality and survival. Blood serum concentration of troponin I higher than 165.13 µg/l was an important predictor for in-hospital death with a high degree of significance (р<0.0001). Th degree of RF considerably influenced the in-hospital mortality (р<0.0001). RF severity was associated with LV EF (р=0.024). The SpO2 value determined an adverse immediate prognosis with a high degree of significance (р=0.0009). This parameter weakly correlated with LV EF (r=0.26; p=0.0009). Patients who required artificial ventilation (AV) constituted a group with the worst survival rate (р<0.0001). LV EF was associated with a need for AV with a high degree of significance (р=0.0006). Comorbidities, such as chronic kidney disease, postinfarction cardiosclerosis and oncologic diseases, to the greatest extent determined the risk of fatal outcome. Conclusion EchoCG can be recommended for patients with COVID-19 at the hospital stage to determine the tactics of management and for the in-hospital prognosis.

Verified
Journal Article
Open access
PDF file
ABAzamat Baymukanov
Azamat Baymukanov
YWYuliya Weissman
Yuliya Weissman
IBIrina Andreevna Bulavina
Irina Andreevna Bulavina
IIIlya Leonidovich Ilyich
Ilya Leonidovich Ilyich
STSergey Arturovich Termosesov
Sergey Arturovich Termosesov
Introduction: Obstructive sleep apnea (OSA) is associated with an increased risk of hypertension, coronary artery disease, heart failure (HF), and atrial fibrillation (AF). Materials and methods: A total of 179 patients aged 34–81 years were included in the study. The median age was 63 years (interquartile range: 56–69 years). Of these patients, 105 (58.7%) were men, and 74 (41.3%) were women; there were cases of paroxysmal (n = 99), persistent (n = 64), and permanent AF (n = 16). All patients underwent investigations including respiratory sleep monitoring, echocardiography, and 24 h Holter electrocardiography monitoring. Statistical analyses were performed using IBM SPSS Statistics 26.0. Results: OSA was detected in 131 (73.2%) patients. In patients with OSA, paroxysmal AF was commonest (n = 65), followed by persistent AF (n = 51) and permanent AF (n = 15). The patients with sleep apnea had increased body mass index (33.6 kg/m2; p = 0.02), waist circumference (114 cm; p < 0.001), and neck circumference (42 cm; p < 0.001) values. HF (OR 2.9; 95% CI: 1.4–5.9; p = 0.004) and type 2 diabetes (OR 3.6; 95% CI: 1.5–8.3; p = 0.001) were more common in patients with AF and OSA. The STOP-BANG scale (AUC = 0.706 ± 0.044; 95% CI: 0.619–0.792; p < 0.001) and the Berlin questionnaire (AUC = 0.699 ± 0.044; 95% CI: 0.614–0.785) had a higher predictive ability for identifying sleep apnea. Conclusions: Patients with AF demonstrate a high prevalence of OSA and an increased association with cardiovascular comorbidities. The STOP-BANG scale and the Berlin questionnaire can be used to screen for OSA in patients with AF.

1 January 2017 in Kardiologiia
Verified
Journal Article
Closed access
ABAzamat Baymukanov
Azamat Baymukanov
GGG. E. Gendlin
G. E. Gendlin
INIGOR G. NIKITIN
IGOR G. NIKITIN
IKI. A. Khamnagadaev
I. A. Khamnagadaev
STS. A. Termosesov
S. A. Termosesov
III. L. Iljich
I. L. Iljich
To study prevalence of left ventricular diastolic dysfunction (LVDD) and to evaluate the effect of pulmonary vein catheter isolation on left ventricular (LV) diastolic function in patients with paroxysmal and persistent forms of atrial fibrillation (AF). 109 patients with paroxysmal (n=90; 82.6 %) and persistent (n=19; 17.4 %) AF were evaluated after 109 pulmonary vein catheter isolations. The patients were divided into two groups based on the operation efficacy. Heart ultrasound including evaluation of the LV diastolic function was performed for all patients on the day of operation and at 6 and 12 months. After the surgery, 61 (56.5 %) patients maintained sinus rhythm (SR) for 12 months and comprised Group 1. Group 2 consisted of patients with a relapse of AF (47 patients; 43.5 %). At baseline, LVDD with SR was observed in 53 patients (48.6 %), at 6 months - in 34 (31.2 %) patients (p=0.001), and at 12 months - in 27 patients (24.8 %) (p.

9 January 2024 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
IBI. A. Bulavina
I. A. Bulavina
YVYu. D. Vaisman
Yu. D. Vaisman
ABAzamat Baymukanov
Azamat Baymukanov
MYM. V. Yunyaeva
M. V. Yunyaeva
III. L. Ilyich
I. L. Ilyich
ЮВЮ. Д. Вайсман
Ю. Д. Вайсман
In recent decades, there has been increased interest in obstructive sleep apnea (OSA), especially in patients with a combination of OSA and sleep bradyarrhythmias. Worldwide, the diagnosis of OSA is steadily increasing. Increasingly, clinicians have begun to use CPAP therapy to treat sleep-related bradyarrhythmias. But in world practice there are no unambiguous guidelines for the management of this group of patients.

17 February 2025 in Russian Medicine
Verified
Journal Article
Closed access
MYMaria V. Yunyaeva
Maria V. Yunyaeva
IBIrina Andreevna Bulavina
Irina Andreevna Bulavina
ABAzamat Baymukanov
Azamat Baymukanov
YWYuliya Weissman
Yuliya Weissman
AEArtem Anatolyevich Evmenenko
Artem Anatolyevich Evmenenko
ВДВайсман Юлия Дмитриевна
Вайсман Юлия Дмитриевна
BACKGROUND: Obstructive sleep apnea (OSA) is associated with various cardiovascular diseases, including arterial hypertension, chronic heart failure, and cardiac rhythm and conduction disorders. In some patients, preexisting bradycardia may not be directly related to OSA. Therefore, it is advisable to rule out OSA in patients referred for pacemaker implantation. CLINICAL CASES DESCRIPTION: OSA is a common condition frequently associated with bradyarrhythmias. In some cases, treatment for such patients involves the implantation of a permanent endocardial pacemaker. Undiagnosed OSA may lead to an increased number of unnecessary pacemaker implantations, emphasizing the importance of timely diagnosis and treatment of this condition. This article presents clinical observations of seven patients with nocturnal bradyarrhythmias, which resolved following continuous positive airway pressure (CPAP) therapy. The use of CPAP therapy contributed to the improvement of cardiovascular parameters, including the reduction in the number and duration of heart rhythm pauses. Clinically significant bradyarrhythmias were resolved in patients, allowing them to avoid surgical intervention. In the described cases, patients demonstrated a high apnea–hypopnea index (35.0–79.5 episodes per hour), a significant decrease in blood oxygen saturation (minimum up to 50%), and significant heart rhythm disturbances during the night. The initiation of CPAP therapy led to a reduction in the apnea–hypopnea index (1.9–23.1 episodes per hour), normalization of minimum oxygen saturation (80–93%), and the elimination of prolonged rhythm pauses. CONCLUSION: The findings highlight the necessity of mandatory screening for OSA in patients with nocturnal bradyarrhythmias before planning pacemaker implantation. CPAP therapy effectively eliminates rhythm disturbances associated with sleep apnea and prevents unnecessary surgical procedures. This confirms the importance of a comprehensive approach to the diagnosis and treatment of this category of patients and the need for further large-scale studies to optimize their management tactics.

31 December 2022 in Kardiologiia
Verified
Journal Article
Open access
PDF file
IKI. V. Kovtyukh
I. V. Kovtyukh
ABAzamat Baymukanov
Azamat Baymukanov
GGG. E. Gendlin
G. E. Gendlin
INIGOR G. NIKITIN
IGOR G. NIKITIN
SDS. N. Dvornikova
S. N. Dvornikova
OROlga Roginko
Olga Roginko
Aim      To determine the effect of major electrocardiographic (ECG) parameters on the prognosis of patients with COVID-19. Material and methods  One of systemic manifestations of COVID-19 is heart injury. ECG is the most simple and available method for diagnosing the heart injury, which influences the therapeutic approach. This study included 174 hospitalized patients with COVID-19. Major ECG parameters recorded on admission and their changes before the discharge from the hospital or death of the patient, were analyzed, and the effect of each parameter on the in-hospital prognosis was determined. Results were compared with the left ventricular ejection fraction (LV EF), laboratory data, and results of multispiral computed tomography (MSCT) of the lungs. Results ECG data differed on admission and their changes differed for deceased and discharged patients. Of special interest was the effect of the QRS complex duration at baseline and at the end of treatment on the in-hospital survival and mortality rate. The Cox regression analysis showed that the QRS complex duration (relative risk (RR) 2.07, 95% confidence interval (CI): 1.17–3.66; р=0.01), MSCT data (RR, 1.54; 95 % CI: 1.14–2.092; р=0.005), and glomerular filtration rate (GFR) (RR, 0.98; 95 % CI: 0.96–0.99; р=0.001) had the highest predictive significance. In further comparison of these three indexes, the QRS duration and GFR retained their predictive significance, and a ROC analysis showed that the cut-off QRS complex duration was 125 ms (р=0.001). Patients who developed left bundle branch block (LBBB) in the course of disease also had an unfavorable prognosis compared to other intraventricular conduction disorders (р=0.038). The presence of LBBB was associated with reduced LV EF (р=0.0078). The presence of atrial fibrillation (AF) significantly predetermines a worse outcome both at the start (р=0.011) and at the end of observation (р=0.034). A higher mortality was observed for the group of deceased patients with ST segment deviations, ST elevation (р=0.0059) and ST depression (р=0.028). Conclusion      Thus, the QTc interval elongation, LBBB that developed during the treatment, AF, and increased QRS complex duration are the indicators that determine the in-hospital prognosis of patients with COVID-19. The strongest electrocardiographic predictor for an unfavorable prognosis was the QRS complex duration that allowed stratification of patients to groups of risk.